Abstract:Organophosphate esters (OPEs) can exhibit various toxicities including endocrine disruption activity. Unfortunately, the low-dose endocrine-disrupting effects mediated by estrogen receptors (ERs) are commonly underestimated for OPEs and their metabolites. Here, structure-oriented research was performed to investigate the estrogenic/antiestrogenic effect of 13 OPEs (including three metabolites) and the potential mechanism. All of the OPEs exerted antiestrogenic activities in both E-screen and MVLN assays. OPEs with bulky substituents, such as phenyl rings (triphenyl phosphate (TPP), tricresyl phosphate (TCP), diphenylphosphoryl chloride, and diphenylphosphite) or relatively long alkyl chains (dibutylbutylphosphonate (DBBP)), exerted relatively strong ER antagonism potency at micromolar concentrations. The established quantitative structure–activity relationship indicated that the antiestrogenic activities of the OPEs mainly depended on the volume, leading eigenvalue, and hydrophobicity of the molecule. Molecular docking revealed that the three OPEs with the bulkiest substituents on the phosphate ester group (TPP, TCP, and DBBP) have a similar interaction mode to the classical ER antagonist 4-hydroxytamoxifen. The correlation between the antiestrogenic activity and the corresponding ER binding affinity was statistically significant, strongly suggesting that the OPEs possess the classical antagonism mechanism of interfering with the positioning of helix 12 in the ER.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.est.0c04376?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.est.0c04376</a>.Docking scores, molecular parameters, and activity data of OPEs (Table S1); RNA isolation and reverse transcription polymerase chain reaction (RT-PCR) (Part 1); the process of QSAR development and the robustness of the QSAR model (Part 2); antiproliferation effect of each OPE in the E-screen assay under single exposure scenario (Figure S1); antiluciferase activities of OPEs after cotreatment with E2 in the MVLN assay (Figure S2); empirical distribution of R2* for the PEC50 model in the antiproliferation activity of OPEs (cotreatment with E2) in the E-screen assay (Figure S3); empirical distribution of R2* for the PEC50 model in the antiluciferase activity of OPEs (exposure alone) in the MVLN assay (Figure S4); empirical distribution of R2* for the PEC50 model in the antiluciferase activity of OPEs (cotreatment with E2) in the MVLN assay (Figure S5); and the binding modes of five OPE molecules in hERα-LBD (Figure S6) (<a class="ext-link" href="/doi/suppl/10.1021/acs.est.0c04376/suppl_file/es0c04376_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

The Interaction Between Organic Phosphate Ester and P53: an Integrated Experimental and in Silico Approach.

Molecular Modeling and Molecular Dynamics Simulation Studies on the Interactions of Hydroxylated Polychlorinated Biphenyls with Estrogen Receptor-β

Molecular Docking, Molecular Dynamics Simulation, and Structure-Based 3D-QSAR Studies on the Aryl Hydrocarbon Receptor Agonistic Activity of Hydroxylated Polychlorinated Biphenyls.

Investigation on the interaction of aromatic organophosphate flame retardants with human serum albumin via computer simulations, multispectroscopic techniques and cytotoxicity assay

Computational Insight into Biotransformation Profiles of Organophosphorus Flame Retardants to Their Diester Metabolites by Cytochrome P450

Determination of the binding affinities of OPEs to integrin α v β 3 and elucidation of the underlying mechanisms via a competitive binding assay, pharmacophore modeling, molecular docking and QSAR modeling

Cytotoxicity evaluation of organophosphorus flame retardants using electrochemical biosensors and elucidation of associated toxic mechanisms

Genetic comprehension of organophosphate flame retardants, an emerging threat to prostate cancer

The mechanism of interaction between tri-para-cresyl phosphate and human serum protein: A multispectroscopic and in-silico study

Exploring the Binding Mechanism Between Human Profilin (PFN1) and Polyproline-10 Through Binding Mode Screening

Organophosphorus Flame Retardants and Metabolic Disruption: An in Silico , in Vitro , and in Vivo Study Focusing on Adiponectin Receptors

Structure-Oriented Research on the Antiestrogenic Effect of Organophosphate Esters and the Potential Mechanism

A green approach coupled with molecular dynamics simulations and toxicity assays to infer the mode of action for organophosphate esters

Analysis of Binding Modes between Three Perfluorosulfonates and GPER Based on Computational Simulation and Multiple Spectral Methods

The investigation of the toxicity of organophosphorus flame retardants (OPFRs) by using in silico toxicity prediction platform ProTox- 3.0

Potential Estrogenic Effects Of Phosphorus-Containing Flame Retardants

Structure-dependent destructive adsorption of organophosphate flame retardants on lipid membranes

Exploring the environmental contamination toxicity and potential carcinogenic pathways of perfluorinated and polyfluoroalkyl substances (PFAS): An integrated network toxicology and molecular docking strategy

Comprehensive analysis of triphenyl phosphate: An environmental explanation of colorectal cancer progression

In Vitro Oxidative Stress, Mitochondrial Impairment and G1 Phase Cell Cycle Arrest Induced by Alkyl-Phosphorus-containing Flame Retardants

Identification of a 1, 8-naphthyridine-containing compound endowed with the inhibition of p53-MDM2/X interaction signaling: a computational perspective